Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra.

The effects of seganserin, a specific 5HT2 antagonist, on human sleep were assessed in two experiments and compared to the effects of temazepam and sleep deprivation. During daytime recovery sleep after sleep deprivation, seganserin did not significantly enhance visually scored slow wave sleep (SWS, stages 3 + 4) or the EEG power density in the delta frequencies. Under these conditions temazepam reduced the power density in the delta and theta frequencies. During nighttime sleep after a nap in the evening, seganserin caused an increase in SWS, a reduction in intermittent wakefulness, and an enhancement of the power density in the delta and theta frequencies during non-rapid eye movement (NREM) sleep. Temazepam induced a reduction in the power density in the delta and theta frequencies. It is concluded that the 5HT2 antagonist, seganserin, can induce SWS. However, since the spectral results showed that the changes in the sleep EEG were not identical to those induced by sleep deprivation it seems premature to conclude that 5HT2 receptors are primarily involved in NREM sleep regulation.

[1]  A. Borbély.  A two process model of sleep regulation. , 1982, Human neurobiology.

[2]  C. Dugovic,et al.  5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. , 1987, European journal of pharmacology.

[3]  M. Janssen,et al.  The chemical development of selective and specific serotonin S2‐antagonists , 1986 .

[4]  A. Rechtschaffen,et al.  A manual of standardized terminology, technique and scoring system for sleep stages of human subjects , 1968 .

[5]  D Lehmann,et al.  Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. , 1985, Human neurobiology.

[6]  S. Daan,et al.  Timing of human sleep: recovery process gated by a circadian pacemaker. , 1984, The American journal of physiology.

[7]  I Feinberg,et al.  Homeostatic changes during post-nap sleep maintain baseline levels of delta EEG. , 1985, Electroencephalography and clinical neurophysiology.

[8]  R L Williams,et al.  The effects of naps on nocturnal sleep: influence on the need for stage-1 REM and stage 4 sleep. , 1970, Biological psychiatry.

[9]  L. Fuccella.  Bioavailability of temazepam in soft gelatin capsules. , 1979, British journal of clinical pharmacology.

[10]  A. Borbély,et al.  Effect of ritanserin on sleep stages and sleep EEG in the rat. , 1988, European journal of pharmacology.

[11]  D. Dijk,et al.  Effects of SWS deprivation on subsequent EEG power density and spontaneous sleep , 2002 .

[12]  D Lehmann,et al.  Sleep deprivation: effect on sleep stages and EEG power density in man. , 1981, Electroencephalography and clinical neurophysiology.

[13]  T. Åkerstedt,et al.  The circadian variation of experimentally displaced sleep. , 1981, Sleep.

[14]  C. Idzikowski,et al.  5-Hydroxytryptamine-2 antagonist increases human slow wave sleep , 1986, Brain Research.

[15]  J. Leysen,et al.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. , 1985, Molecular pharmacology.

[16]  A. C. Declerck,et al.  Increase in slow-wave sleep in humans with the serotonin-S2 antagonist ritanserin: the first exploratory polygraphic sleep study , 1987 .

[17]  E. Wolpert.  A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[18]  J. Leysen,et al.  The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat , 1989, Pharmacology Biochemistry and Behavior.

[19]  S. Daan,et al.  EEG Power Density during Nap Sleep: Reflection of an Hourglass Measuring the Duration of Prior Wakefulness , 1987, Journal of biological rhythms.

[20]  Homeostatic changes in slow wave sleep during recovery sleep following restricted nocturnal sleep and partial slow wave sleep recovery during an afternoon nap. , 1987, Sleep.